| 2nd Feb 2009 2:33 pm |
RNS |
Cephalon license exercise |
| 30th Jan 2009 7:00 am |
RNS |
Successful trial results |
| 22nd Dec 2008 12:00 pm |
RNS |
further instalment of grant |
| 25th Nov 2008 7:00 am |
RNS |
Option Agreement with Cephalon |
| 12th Nov 2008 7:00 am |
RNS |
Grant Award |
| 21st Oct 2008 9:31 am |
RNS |
Patents Granted |
| 17th Oct 2008 4:22 pm |
RNS |
Additional Listing and Total Voting Rights |
| 25th Sep 2008 7:00 am |
RNS |
Interim Results |
| 5th Aug 2008 3:44 pm |
RNS |
AGM Result |
| 10th Jul 2008 7:00 am |
RNS |
Second Placing |
| 2nd Jul 2008 7:30 am |
RNS |
Toxicology study |
| 2nd Jul 2008 7:00 am |
RNS |
Fund Raising |
| 30th Jun 2008 3:00 pm |
RNS |
Annual Report and Accounts |
| 20th May 2008 7:00 am |
RNS |
Pre-clinical Data |
| 13th May 2008 6:00 am |
RNS |
Trademark Approval |
| 8th May 2008 7:00 am |
RNS |
Preliminary Results |
| 26th Feb 2008 7:00 am |
RNS |
Phase IIb Trial of IPP-201101 |
| 8th Jan 2008 7:00 am |
RNS |
Novel Drug Candidate |
| 18th Dec 2007 12:51 pm |
RNS |
Directors' Dealings |
| 6th Dec 2007 7:01 am |
RNS |
Initiation of Phase IIb trial |
| 16th Nov 2007 12:28 pm |
RNS |
Appointment of Nomad |
| 28th Sep 2007 7:02 am |
RNS |
Interim Results |
| 22nd Aug 2007 7:00 am |
RNS |
Compound Discovery |
| 20th Aug 2007 10:17 am |
RNS |
AIM Rule 26 |
| 13th Aug 2007 4:17 pm |
RNS |
Directors' Dealing |
| 6th Aug 2007 2:40 pm |
RNS |
Grant of Options |
| 10th Jul 2007 7:01 am |
RNS |
Pivotal phase II/III trial |
| 13th Jun 2007 2:00 pm |
RNS |
AGM and Board Update |
| 1st May 2007 7:02 am |
RNS |
Preliminary Results |
| 27th Apr 2007 4:02 pm |
RNS |
Board Appointment |
| 15th Feb 2007 7:01 am |
RNS |
Appointment of adviser |
| 7th Feb 2007 7:01 am |
RNS |
Board Changes |
| 19th Jan 2007 8:57 am |
RNS |
Total Voting Rights |
| 5th Jan 2007 2:27 pm |
RNS |
Issue of Equity |
| 27th Dec 2006 2:53 pm |
RNS |
Total Voting Rights |
| 21st Dec 2006 7:01 am |
RNS |
Issue of Equity |
| 30th Oct 2006 7:01 am |
RNS |
Further Phase II Data |
| 17th Oct 2006 7:00 am |
RNS |
Phase II Data |
| 2nd Oct 2006 7:01 am |
RNS |
FDA Meeting on Lupus |
| 26th Sep 2006 7:01 am |
RNS |
Interim Results |
